Images

<p class="p1"><b>PT-141 (Bremelanotide) — Melanocortin-4 Agonist Peptide</b><b></b></p> <p class="p3">Explore neuroendocrine pathways of sexual arousal and vascular tone with PT-141, a cyclic heptapeptide that selectively activates MC-4R and MC-1R. Pre-clinical and Phase 2/3 data show rapid, transient increases in libido and penile/clitoral blood flow, making PT-141 a valuable tool for studying hypoactive sexual desire and erectile physiology.</p> <ul> <li> <p class="p1"><span class="s1"><b>Purity:</b></span> &gt; 99 % (HPLC)</p> </li> <li> <p class="p1"><span class="s1"><b>Molecular Weight:</b></span> ≈ 1.03 kDa (C₅₀H₆₈N₁₄O₁₀)</p> </li> <li> <p class="p1"><span class="s1"><b>Form &amp; Size:</b></span> Lyophilized powder in <span class="s1"><b>10 mg</b></span> research-grade vials</p> </li> <li> <p class="p1"><span class="s1"><b>Solubility:</b></span> Sterile water or 0.6 – 0.9 % saline</p> </li> <li> <p class="p1"><span class="s1"><b>Storage:</b></span> −20 °C long-term; reconstituted aliquots ≤ −80 °C; stable ≤ 24 h at room temperature when protected from light</p> </li> </ul> <p><em>For laboratory research use only. Not for human or veterinary administration. Although FDA-approved as <span class="s3"><b>Vyleesi® (2019)</b></span> for HSDD in pre-menopausal women, this product is supplied solely for controlled in-vitro or pre-clinical experimentation.</em></p>

Research supply

PT-141

Product information

PT-141

$34.00

Product options

Default
$34.00
Qty

COA available

Certificates of Analysis for this batch

View the Certificate of Analysis for the in-stock lot(s) below.

Have a lot number? Look up your COA.

Product notes

PT-141 (Bremelanotide) — Melanocortin-4 Agonist Peptide

Explore neuroendocrine pathways of sexual arousal and vascular tone with PT-141, a cyclic heptapeptide that selectively activates MC-4R and MC-1R. Pre-clinical and Phase 2/3 data show rapid, transient increases in libido and penile/clitoral blood flow, making PT-141 a valuable tool for studying hypoactive sexual desire and erectile physiology.

  • Purity: > 99 % (HPLC)

  • Molecular Weight: ≈ 1.03 kDa (C₅₀H₆₈N₁₄O₁₀)

  • Form & Size: Lyophilized powder in 10 mg research-grade vials

  • Solubility: Sterile water or 0.6 – 0.9 % saline

  • Storage: −20 °C long-term; reconstituted aliquots ≤ −80 °C; stable ≤ 24 h at room temperature when protected from light

For laboratory research use only. Not for human or veterinary administration. Although FDA-approved as Vyleesi® (2019) for HSDD in pre-menopausal women, this product is supplied solely for controlled in-vitro or pre-clinical experimentation.

You may also like